EZH2 and B-cell non-Hodgkin lymphoma: Interestingly, both EZH1 and EZH2 are functional not only in multiple lymphomas with wild-type EZH2 but also in certain B-cell lymphomas with heterozygous mutant EZH2, and the dual inhibitor is more effective.